Literature DB >> 10102640

Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae.

E Arvå1, B Andersson.   

Abstract

The aim of this study was to describe the kinetics of the cytokine release and the expression of activation markers on lymphocytes after stimulation of peripheral blood mononuclear cells (PBMC) with whole killed Streptococcus pneumoniae. The cytokine release and the expression of CD25 and HLA-DR on T cells, and CD69 on T cells, B cells and NK cells, were measured at different times. Our results show that tumour necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-10 and IL-12 reached maximal levels at 24 h, while IL-6, IL-8, TNF-beta and interferon (IFN)-gamma increased throughout the 1-week test period. The strains tested gave an increased expression of CD69 on all cell types, as well as an increase of CD25 and HLA-DR expression on T cells. The maximal CD69 expression was seen after 24 h on T cells and NK cells, while the B-cell expression of CD69 reached a plateau at the same time. All the cells still expressed CD69 on their surfaces after 1 week. In conclusion the results indicate that there was probably an early activation of monocytes leading to a polyclonal activation of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102640     DOI: 10.1046/j.1365-3083.1999.00470.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  16 in total

1.  Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma.

Authors:  Ajay V Maker; James C Yang; Richard M Sherry; Suzanne L Topalian; Udai S Kammula; Richard E Royal; Marybeth Hughes; Michael J Yellin; Leah R Haworth; Catherine Levy; Tamika Allen; Sharon A Mavroukakis; Peter Attia; Steven A Rosenberg
Journal:  J Immunother       Date:  2006 Jul-Aug       Impact factor: 4.456

2.  Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.

Authors:  L Baril; J Dietemann; M Essevaz-Roulet; L Béniguel; P Coan; D E Briles; B Guy; G Cozon
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.

Authors:  Ajay V Maker; Peter Attia; Steven A Rosenberg
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 4.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

5.  CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  An immunosuppressive antibody-drug conjugate.

Authors:  Rongsheng E Wang; Tao Liu; Ying Wang; Yu Cao; Jintang Du; Xiaozhou Luo; Vishal Deshmukh; Chan Hyuk Kim; Brian R Lawson; Matthew S Tremblay; Travis S Young; Stephanie A Kazane; Feng Wang; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2015-02-27       Impact factor: 15.419

7.  Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.

Authors:  Tamika Burns; Zhaojing Zhong; Michael Steinitz; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.

Authors:  H Kaushal; R Bras-Gonçalves; K Avishek; D Kumar Deep; E Petitdidier; J-L Lemesre; G Papierok; S Kumar; V Ramesh; P Salotra
Journal:  Clin Exp Immunol       Date:  2016-05-04       Impact factor: 4.330

9.  A new and robust method of tethering IgG surrogate antigens on lipid bilayer membranes to facilitate the TIRFM based live cell and single molecule imaging experiments.

Authors:  Shaosen Zhang; Liling Xu; Xingwang Zhao; Xin Chen; Yilin Fan; Zhengpeng Wan; Yinsheng Xu; Wanli Liu
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial.

Authors:  B Funke; H K Maerz; S Okorokow; S Polata; I Lehmann; U Sack; P Wild; T Geisler; R J Zotz
Journal:  Cardiovasc Ultrasound       Date:  2004-09-10       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.